Method for minimizing excess collagen deposition
US6472434B1 · kind B1 · utility
96Cited by
23References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2000 |
| Grant date | Oct 29, 2002 |
| Priority date | — |
| Expiry date | Mar 30, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and formulations for minimizing excess collagen are provided. A pharmaceutical composition formulated so as to contain a selected vasoactive agent is administered to the vagina, vulvar area or urethra of the individual undergoing treatment. Suitable vasoactive agents are vasodilators, including naturally occurring prostaglandins, synthetic prostaglandin derivatives, endothelial-derived relaxation factors, vasoactive intestinal polypeptide agonists, smooth muscle relaxants, leukotriene inhibitors, and others.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.